Capecitabine EP Impurity M
 
		Product Description
CAT No.
				
									ALN-C003022								
				CAS No.
				
									NA								
				Mol. F.
				
									C11H14FN3O6								
				Mol. Wt.
				
									303.3								
				Stock
				
									Please Inquire								
				
										
							
										Product Overview
						
											
										
							
										Technical Data
						
											
										
							
										Reference
						
											
										
							
										RFQ
						
									
							
							
							Product Overview
			
						
									Chemical Name : (1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)methyl carbamate								
				
									Smiles : C[C@H]1O[C@@H](N2C=C(F)C(COC(N)=O)=NC2=O)[C@H](O)[C@@H]1O								
				
									Inchi : InChI=1S/2C15H22FN3O6/c1-7(2)4-5-24-15(23)18-12-9(16)6-19(14(22)17-12)13-11(21)10(20)8(3)25-13;1-4-7(2)6-24-15(23)18-12-9(16)5-19(14(22)17-12)13-11(21)10(20)8(3)25-13/h6-8,10-11,13,20-21H,4-5H2,1-3H3,(H,17,18,22,23);5,7-8,10-11,13,20-21H,4,6H2,1-3H3,(H,17,18,22,23)/t8-,10-,11-,13-;7?,8-,10-,11-,13-/m11/s1								
				
							
							
							Technical Data
			
						
							
							
							Reference
			
						Design of experiments (DoE) - based enhanced quality by design approach to hydrolytic degradation kinetic study of capecitabine by eco-friendly stability indicating UV-visible spectrophotometry
									By Prajapati, Pintu; Patel, Radhika; Patel, Dilan; Shah, ShaileshnFrom American Journal of PharmTech Research (2020), 10(6), 115-133								
				Validated stability indicating HPLC method for estimation of capecitabine
									By Lalitha, K. V.; Raveendra Reddy, J.; Devanna, N. – From International Journal of Pharmaceutical Sciences and Research (2020), 11(11), 5651-5658 								
				RP-HPLC method development and validation for the simultaneous estimation of Irinotecan hydrochloride and Capecitabine in Active Pharmaceutical Ingredients (APIs)
									By Vijaya Jyothi, M.; Bhargav, E.; Keerthana, B.; Varalakshmi, Devi K. – From International Journal of Research in Pharmaceutical Sciences (Madurai, India) (2018), 9(1), 63-67								
				
							
							
							RFQ
			
						
 
                             
                             
                             
                             
                            